StockData
GSK plc logo

GSK plc (GSK) income statement

GSKNYSEPharmaceutical PreparationsAlso trades as GLAXF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 9/30
$47.82−0.76 (-1.56%)

Close on Nov 19, 2026Market cap $103.18BP/E 13.0Yield –

GSK plc income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
72.4%
Operating margin
24.3%
Net margin
17.5%
Return on equity, FY2025
38.0%

Financial strength

Current ratio
0.82
Debt to equity
1.08
Debt to assets
29.0%
Cash to current liabilities
15.9%

Valuation

P/E ratio
13.0
Price to sales
2.39
Price to book
4.77
Dividend yield
–

See a number that looks wrong?